Miami Cancer Institute Women’s Cancer Symposium, Second Annual

April 16, 2021
image

Live Virtual Symposium - April 16, 2021

The Miami Cancer Institute Women’s Cancer Symposium brings together a distinguished faculty for a one-day virtual symposium that will focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer. The multispecialty approach allows participants to explore new diagnoses and cutting-edge treatment options for various areas of breast and ovarian cancer patient care in a concise symposium format.

ENROLL Today →  Become an Exhibitor →

Miami Cancer Institute Launches Breast Cancer Prevention ClinicExpand DropdownClose Dropdown

 

Physicians and other medical professionals at Miami Cancer Institute are as focused on providing lifesaving treatments for women with breast cancer as they are dedicated to preventing the disease.

Learn More

Learning Objectives

Upon completion of this conference, participants should be better able to:

  • Identify and explain the latest trends in research and technology in the treatment of gynecologic and breast cancers.
  • Interpret contemporary research findings and be able to appropriately implement changes into clinical practice.
  • Examine the significance of novel approaches to the medical and surgical management of breast and gynecologic cancers within the context of the current standard of care.
  • Integrate new gynecologic oncology therapies into clinical practice in an evidence-based manner.
  • Amplify implementation of novel approaches to the clinical care team.
  • Assess the implications for future directions in research and clinical practice in breast and gynecologic cancers.

Who Should Attend

Breast Surgeons, General Surgeons, Reconstructive Surgeons, Obstetricians and Gynecologists, Oncologists, Medical Oncologists, Physiatrists, Radiation Oncologists, Pathologists, Geneticists, Radiologists, General Practitioners, Nurses and all other interested healthcare professionals.

Registration and Fees

This live virtual symposium is offered free of charge.

Event date: April 16, 2021

ENROLL Today →

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 General certificate of attendance
  • 6.00 Nurse Practitioners
  • 6.00 Florida Board of Nursing
  • 6.00 Florida Board of Occupational Therapy
  • 6.00 Florida Board of Pharmacy
  • 6.00 Florida Board of Respiratory Therapy
Course opens: 
02/15/2021
Course expires: 
06/28/2021
Event starts: 
04/16/2021 - 7:45am
Event ends: 
04/16/2021 - 3:30pm

Agenda

7:45 - 8:00 a.mIntroductions
Gladys Giron, M.D.

Opening Remarks: Miami Cancer Institute: Impact on Cancer Care in South Florida
Michael Zinner, M.D.
 MODERATOR: Jane Mendez, M.D. 
8:00-8:20 a.m.Building a Research Consortium
Paul Sabbatini, M.D.
8:20 - 8:45 a.m.De-escalation of Chemotherapy for Early Stage Breast Cancers
Rachel Sanford, M.D.
8:45 - 9:05 a.m.Advances in Cardio-oncology in Cancer Treatment
Ranju Gupta, M.D.
9:05 - 9:25 a.m.Updates on the Management of Metastatic Breast Cancer
Ana C. Sandoval Leon, M.D.
9:25 - 9:35 a.m.Break
 MODERATOR: Starr Mautner, M.D. 
9:35 - 10:00 a.m.Contrast-enhanced Spectral Mammography
Kathy J. Schilling, M.D. 
10:00 - 10:25 a.m.Update on Breast Cancer Prevention Options and RISE Program
Melissa Pilewskie, M.D.
10:25 - 10:45 a.m.Advances in Oncoplastic Techniques in Breast Reduction
Harry Salinas, M.D.
10:45 - 11:10 a.m.External Beam Partial Breast Irradiation and MSK 19-300 Alliance Trial
Erin Gillespie, M.D.
11:10 a.m. - 11:55 a.m.Lunch
 MODERATOR: Gladys Giron, M.D. 
12:00 - 12:20 p.m. Sexual Health and Cancer
Jeanne Carter, Ph.D.
12:20 - 12:40 p.m.Standards for Germline Testing for Hereditary Breast and Ovarian Carcinoma Upon Diagnosis- A Rapidly Moving Target
Daniel Morganstern, M.D.
12:40 - 1:00 p.m.The Role of Integrative Medicine in Breast and Gynecologic Cancers
Ting Bao, M.D.
1:00 - 1:10 p.m.Break
 MODERATOR: John Diaz, M.D. 
1:10 -1:35 p.m.Surgical Management of High-risk Endometrial Cancer: Should Sentinel Lymph Node be the Standard
Ginger Gardner, M.D.
1:35 - 1:55 p.m.Immunotherapy in the Management of Endometrial Cancer
Shannon Westin, M.D.
1:55 - 2:20 p.m.Developing Strategies to Prevent Gynecologic Cancers 
Martin A. Martino, M.D. 
2:20-2:30 p.m.Break
 MODERATOR: Nicholas Lambrou, M.D. 
2:30-2:50 p.m.The Role of Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian Cancer
Oliver Zivanovic, M.D.
2:50-3:15 p.m.Maintenance Therapy for Newly Diagnosed Ovarian Cancer: PARP Inhibitors, Bevacizumab, or Both? (or Perhaps Neither)
Jason Konner, M.D.
3:15 p.m.Closing Remarks
John Diaz, M.D. 
3:25p.m.Adjourn

NOTE: Schedule subject to change.

Symposium Directors

John P. Diaz, M.D., FACOGJohn P. Diaz, M.D., FACOG
Deputy Chief of Gynecologic Oncology
Lead Physician for Clinical Trials in Gynecologic Oncology
Miami Cancer Institute
Chief, Center of Excellence in Minimally Invasive Gynecologic Surgery
Baptist Health South Florida
Gladys L. Giron, M.D., FACSGladys L. Giron, M.D., FACS 
Breast Surgical Oncology 
Cancer Liaison Physician 
Miami Cancer Institute 
Nicholas C. Lambrou, M.D., FACOGNicholas C. Lambrou, M.D., FACOG
Chief of Gynecologic Oncology, Miami Cancer Institute
Director of Robotic Surgery, Baptist Health South Florida
Associate Professor, Herbert Wertheim College of Medicine
Florida International University
Starr K. Mautner, M.D., FACSStarr K. Mautner, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician
Miami Cancer Institute

Faculty

Ting Bao, M.D.Ting Bao, M.D.
Director of Integrative Breast Oncology
Memorial Sloan Kettering Cancer Center
New York, New York
Jeanne Carter, Ph.D.Jeanne Carter, Ph.D.
Head, Female Sexual Medicine and Women's Health Program
Gynecology Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, New York
Ginger J. Gardner, M.D., FACOGGinger J. Gardner, M.D., FACOG
Section, Ovarian Cancer Surgery;
Physician Lead, Gynecology Disease Management Team Alliance;
Vice Chair of Hospital Operations, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, New York
Erin Gillespie, M.D.Erin Gillespie, M.D.
Assistant Attending Radiation Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York
Ranju Gupta, M.D.Ranju Gupta, M.D.
Attending Physician, Breast Medical Oncologist
Cancer Institute
Lehigh Valley Health Network
Bethlehem, Pennsylvania
Jason A. Konner, M.D.Jason A. Konner, M.D.
Director, GMO New Jersey
Gynecologic Medical Oncology & Early Drug Development
Clinical Member, Memorial Hospital
Memorial Sloan Kettering Cancer Center
New York, New York
Marty Martino, M.D.Martin A. Martino, M.D.
Professor
University of South Florida
College of Medicine, Department of ObGyn
Jane E. Mendez, M.D.Jane E. Mendez, M.D.
Chief, Breast Surgery 
Miami Cancer Institute
Daniel Morganstern, M.D.Daniel Morganstern, M.D.
Medical Oncologist
Hartford HealthCare Cancer Institute
Wethersfield, Connecticut
Melissa L. Pilewskie, M.D., FACSMelissa L. Pilewskie, M.D., FACS
Associate Attending, Breast Services
Director, Strategic Planning and Research, RISE Program
Memorial Sloan Kettering Cancer Center
New York, New York
Paul Sabbatini, M.D.Paul Sabbatini, M.D.
Deputy Physician-in-Chief for Clinical Research
Memorial Sloan Kettering Cancer Center
New York, New York
Harry Salinas, M.D.Harry Salinas, M.D.
Chief of Breast Reconstruction
Miami Cancer Institute
Miami, Florida
Ana Sandoval Leon, M.D.Ana Sandoval Leon, M.D.
Breast Medical Oncologist
Baptist Health Medical Group
Miami, Florida
Rachel Sanford, M.D.Rachel Sanford, M.D.
Medical Oncologist, Breast Cancer
Breast Medicine Clinical Director
Memorial Sloan Kettering Cancer Center
New York, New York
Kathy Jean Schilling, M.D.Kathy Jean Schilling, M.D.
Medical Director
Christine E. Lynn Women’s Health & Wellness Institute
Boca Raton Regional Hospital
Baptist Health South Florida
Boca Raton, Florida
Shannon N. Westin, M.D., MPHShannon N. Westin, M.D., MPH
Associate Professor
Director, Early Drug Development and Phase 1 Trials
Department of Gynecologic Oncology and Reproductive Medicine
UT MD Anderson Cancer Center,
Houston, Texas
Michael Zinner, M.D.Michael J. Zinner, M.D.
Chief Executive Officer and Executive Medical Director
Miami Cancer Institute
Baptist Health South Florida
Miami, Florida
Oliver Zivanovic, M.D., Ph.D.Oliver Zivanovic, M.D., Ph.D.
Section, Ovarian Cancer Surgery
Director, Innovative Surgical Technology
Gynecology Service, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, New York

Disclosures And Resolution Of Conflict Of Interest

Disclosure Policy and Disclaimer

Accreditation

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 6 credit hours, CE Broker Course #830244, by the Florida Boards of Medicine, Osteopathic Medicine, and by the Florida Council of Physician Assistants.

This activity has also been approved for 6 credits for Nursing, Occupational Therapy, Pharmacy, and Respiratory Care (personal growth). Baptist Health South Florida CE Broker Provider #50-182.

Disclaimer

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use. ​​

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 General certificate of attendance
  • 6.00 Nurse Practitioners
  • 6.00 Florida Board of Nursing
  • 6.00 Florida Board of Occupational Therapy
  • 6.00 Florida Board of Pharmacy
  • 6.00 Florida Board of Respiratory Therapy
Please login or register to take this course.


The Miami Cancer Institute Women’s Cancer Symposium will be a fully virtual symposium, allowing learners to access high-quality content and engage remotely from around the world in a platform that has been designed explicitly for this meeting.

Compatibility Notice
image

Google Chrome is recommended to access the live stream to ensure the best experience and optimal connectivity. NOTE: Live streaming is not compatible with Internet Explorer (IE).